OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
September 03, 2022
It is possible to overcome some of the limitations of traditional dosage forms by employing alternative drug delivery formulation strategies.
March 18, 2022
Sanofi is collaborating with Blackstone Life Sciences to accelerate the development of a treatment for multiple myeloma.
February 24, 2022
AstraZeneca and Honeywell will partner to develop next-generation respiratory inhalers as part of AstraZeneca’s Ambition Zero Carbon program.
July 16, 2021
ImmunityBio will proceed with a Phase I/II/III trial in South Africa of their dual-antigen T-cell vaccine as a boost in participants who were previously vaccinated against COVID-19.
July 12, 2021
UltraBurst has a high disintegration speed, which is for all market segments, from prescriptions to nutraceuticals.
June 30, 2021
Modified-release dosage forms present new opportunities for drug developers and can help overcome challenges, such as short biological half-life or poor bioavailability due to degradation in the stomach.
May 03, 2021
Aprecia and Glatt investigate manufacturing technologies to widen the formulation design space for oral delivery.
May 02, 2020
Equipment and process optimization must be considered for scaling up these developmental technologies to commercial production.
April 02, 2020
The new molecules entering the development pipeline are bringing forth exciting challenges in drug delivery.
November 08, 2019
Research examined the effects of varying excipient and polymer weight in coatings designed to optimize the release of diclofenac sodium. The goal was to release it at night to improve the treatment of rheumatoid arthritis.